Moreover, tumor onset and progression were delayed in NSG mice injected with tumor cells derived from hTS/Ink4a/Arf−/− mice, that were transduced with lentiviral TS shRNA compared to control animals injected with cells carrying a non-specific shRNA. This evidence concerns the gene CDKN2A and neoplasm.